Numeric Investors’s Vertex Pharmaceuticals VRTX Stock Holding History

Numeric Investors’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$2.05M	Buy	13,700 +5,100	+59%	+$755K	0.01%	632
2017 Q3	$1.31M	Sell	8,600 -8,900	-51%	-$1.34M	0.01%	696
2017 Q2	$2.25M	Buy	+17,500	New	+$2.11M	0.02%	479
2013 Q4	–	Sell	-264,800	Closed	-$20.1M	–	888
2013 Q3	$20.1M	Buy	264,800 +245,800	+1,294%	+$19.6M	0.37%	60
2013 Q2	$1.52M	Buy	+19,000	New	+$1.4M	0.03%	348

Other funds holding VRTX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Numeric Investors's VRTX Position: Q4 2017 in Review

Numeric Investors increased its Vertex Pharmaceuticals (VRTX) stake by 59% in Q4 2017, buying an estimated $755K and bringing the position to 13,700 shares worth $2.05M. The position accounts for 0.01% of the portfolio, ranked #632.

Numeric Investors first reported a position in VRTX in Q2 2013 and has held it in 5 quarters since. The position peaked at $20.1M in Q3 2013. 644 funds tracked by Wall St. Rank hold VRTX as of Q4 2017.

Numeric Investors held 13,700 shares of Vertex Pharmaceuticals worth $2.05M as of Q4 2017.
Numeric Investors bought 5,100 Vertex Pharmaceuticals shares in Q4 2017, an estimated $755K.
Vertex Pharmaceuticals made up 0.01% of Numeric Investors's portfolio in Q4 2017, its #632 holding.
Numeric Investors first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 5 quarters since.
Numeric Investors's Vertex Pharmaceuticals position peaked at $20.1M in Q3 2013.
644 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2017.

Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.